相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
Christa M. Cobbaert et al.
CLINICAL CHEMISTRY (2021)
PCSK9 Activity Is Potentiated Through HDL Binding
Sean A. Burnap et al.
CIRCULATION RESEARCH (2021)
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
Renato Quispe et al.
EUROPEAN HEART JOURNAL (2021)
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank
Aniruddh P. Patel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study
Capucine Bertrand et al.
DIABETOLOGIA (2021)
Apolipoprotein M and Risk of Type 2 Diabetes
Stefan Hajny et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease
Julia Dittrich et al.
ATHEROSCLEROSIS (2019)
Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
Fernanda A. Orsi et al.
CLINICAL EPIDEMIOLOGY (2019)
Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease
Zhicheng Jin et al.
CLINICAL CHEMISTRY (2019)
Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up
Mathijs C. Bodde et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies A Mendelian Randomization Analysis
Stephen Burgess et al.
JAMA CARDIOLOGY (2018)
Very-Low-Density Lipoprotein- Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
Raimund Pechlaner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Plasma Proteomics for Epidemiology: Increasing Throughput With Standard-Flow Rates
Xiaoke Yin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2017)
Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
Irene van den Broek et al.
CLINICAL CHEMISTRY (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Brendan Nichols et al.
KIDNEY INTERNATIONAL (2015)
Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Anette Varbo et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death
Siqin Zhaorigetu et al.
AUTOPHAGY (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men
Robert Clarke et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue
H Monajemi et al.
GENOMICS (2002)
Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease
F Kronenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
